Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

RDGT vs COR vs MCK vs CAH vs HSIC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
RDGT
Ridgetech Inc.

Medical - Distribution

HealthcareNASDAQ • CN
Market Cap$382.00
5Y Perf.-100.0%
COR
Cencora, Inc.

Medical - Distribution

HealthcareNYSE • US
Market Cap$49.73B
5Y Perf.+168.2%
MCK
McKesson Corporation

Medical - Distribution

HealthcareNYSE • US
Market Cap$92.15B
5Y Perf.+374.1%
CAH
Cardinal Health, Inc.

Medical - Distribution

HealthcareNYSE • US
Market Cap$43.59B
5Y Perf.+238.7%
HSIC
Henry Schein, Inc.

Medical - Distribution

HealthcareNASDAQ • US
Market Cap$8.09B
5Y Perf.+16.1%

RDGT vs COR vs MCK vs CAH vs HSIC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
RDGT logoRDGT
COR logoCOR
MCK logoMCK
CAH logoCAH
HSIC logoHSIC
IndustryMedical - DistributionMedical - DistributionMedical - DistributionMedical - DistributionMedical - Distribution
Market Cap$382.00$49.73B$92.15B$43.59B$8.09B
Revenue (TTM)$259M$328.68B$403.43B$250.55B$13.18B
Net Income (TTM)$7M$2.55B$4.76B$1.56B$398M
Gross Margin8.3%3.5%3.6%3.7%29.1%
Operating Margin-1.8%1.2%1.5%0.9%5.8%
Forward P/E14.5x19.3x17.9x13.3x
Total Debt$10M$10.75B$7.39B$9.35B$3.69B
Cash & Equiv.$13M$4.39B$5.69B$3.87B$156M

RDGT vs COR vs MCK vs CAH vs HSICLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

RDGT
COR
MCK
CAH
HSIC
StockMay 20May 26Return
Ridgetech Inc. (RDGT)1000.0-100.0%
Cencora, Inc. (COR)100268.2+168.2%
McKesson Corporation (MCK)100474.1+374.1%
Cardinal Health, In… (CAH)100338.7+238.7%
Henry Schein, Inc. (HSIC)100116.1+16.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: RDGT vs COR vs MCK vs CAH vs HSIC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CAH leads in 3 of 7 categories (5-stock set), making it the strongest pick for capital preservation and lower volatility and dividend income and shareholder returns. McKesson Corporation is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. RDGT and HSIC also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
RDGT
Ridgetech Inc.
The Niche Pick

RDGT ranks third and is worth considering specifically for efficiency.

  • 8.7% ROA vs CAH's 2.8%, ROIC -2.4% vs 33.8%
Best for: efficiency
COR
Cencora, Inc.
The Lower-Volatility Pick

Among these 5 stocks, COR doesn't own a clear edge in any measured category.

Best for: healthcare exposure
MCK
McKesson Corporation
The Growth Play

MCK is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.

  • Rev growth 16.2%, EPS growth 14.9%, 3Y rev CAGR 10.8%
  • 348.1% 10Y total return vs COR's 269.7%
  • PEG 0.49 vs HSIC's 4.21
  • 16.2% revenue growth vs RDGT's -22.4%
Best for: growth exposure and long-term compounding
CAH
Cardinal Health, Inc.
The Income Pick

CAH carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.

  • Dividend streak 20 yrs, beta 0.03, yield 1.1%
  • Lower volatility, beta 0.03, current ratio 0.94x
  • Beta 0.03, yield 1.1%, current ratio 0.94x
  • Beta 0.03 vs RDGT's 1.10
Best for: income & stability and sleep-well-at-night
HSIC
Henry Schein, Inc.
The Quality Compounder

HSIC is the clearest fit if your priority is quality.

  • 3.0% margin vs CAH's 0.6%
Best for: quality
See the full category breakdown
CategoryWinnerWhy
GrowthMCK logoMCK16.2% revenue growth vs RDGT's -22.4%
ValueMCK logoMCKBetter valuation composite
Quality / MarginsHSIC logoHSIC3.0% margin vs CAH's 0.6%
Stability / SafetyCAH logoCAHBeta 0.03 vs RDGT's 1.10
DividendsCAH logoCAH1.1% yield, 20-year raise streak, vs COR's 0.9%, (2 stocks pay no dividend)
Momentum (1Y)CAH logoCAH+22.0% vs RDGT's -99.1%
Efficiency (ROA)RDGT logoRDGT8.7% ROA vs CAH's 2.8%, ROIC -2.4% vs 33.8%

RDGT vs COR vs MCK vs CAH vs HSIC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

RDGTRidgetech Inc.

Segment breakdown not available.

CORCencora, Inc.
FY 2025
Pharmaceutical Distribution
88.8%$285.3B
International Healthcare Solutions
9.4%$30.4B
Animal Health
1.8%$5.7B
MCKMcKesson Corporation
FY 2025
U.S. Pharmaceutical Segment
91.3%$327.7B
International Segment
4.1%$14.7B
Medical-Surgical Solutions Segment
3.2%$11.4B
Prescription Technology Solutions
1.5%$5.2B
CAHCardinal Health, Inc.
FY 2025
Pharmaceutical Member
91.9%$204.6B
GMPD
5.7%$12.6B
Other Operating Segment
2.4%$5.4B
HSICHenry Schein, Inc.
FY 2018
Healthcare Distribution
96.1%$12.7B
Technology
3.9%$509M

RDGT vs COR vs MCK vs CAH vs HSIC — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLRDGTLAGGINGMCK

Income & Cash Flow (Last 12 Months)

HSIC leads this category, winning 4 of 6 comparable metrics.

MCK is the larger business by revenue, generating $403.4B annually — 1559.2x RDGT's $259M. Profitability is closely matched — net margins range from 3.0% (HSIC) to 0.6% (CAH). On growth, CAH holds the edge at +11.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricRDGT logoRDGTRidgetech Inc.COR logoCORCencora, Inc.MCK logoMCKMcKesson Corporat…CAH logoCAHCardinal Health, …HSIC logoHSICHenry Schein, Inc.
RevenueTrailing 12 months$259M$328.7B$403.4B$250.5B$13.2B
EBITDAEarnings before interest/tax$2M$5.0B$6.8B$3.2B$1.1B
Net IncomeAfter-tax profit$7M$2.5B$4.8B$1.6B$398M
Free Cash FlowCash after capex-$10M$1.6B$6.0B$4.4B$561M
Gross MarginGross profit ÷ Revenue+8.3%+3.5%+3.6%+3.7%+29.1%
Operating MarginEBIT ÷ Revenue-1.8%+1.2%+1.5%+0.9%+5.8%
Net MarginNet income ÷ Revenue+2.6%+0.8%+1.2%+0.6%+3.0%
FCF MarginFCF ÷ Revenue-3.7%+0.5%+1.5%+1.8%+4.3%
Rev. Growth (YoY)Latest quarter vs prior year-11.7%+3.8%+6.0%+11.0%+7.7%
EPS Growth (YoY)Latest quarter vs prior year+97.5%+128.3%+37.0%-19.5%+14.9%
HSIC leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

RDGT leads this category, winning 5 of 7 comparable metrics.

At 21.6x trailing earnings, HSIC trades at a 33% valuation discount to COR's 32.1x P/E. Adjusting for growth (PEG ratio), MCK offers better value at 0.75x vs HSIC's 6.84x — a lower PEG means you pay less per unit of expected earnings growth.

MetricRDGT logoRDGTRidgetech Inc.COR logoCORCencora, Inc.MCK logoMCKMcKesson Corporat…CAH logoCAHCardinal Health, …HSIC logoHSICHenry Schein, Inc.
Market CapShares × price$382$49.7B$92.1B$43.6B$8.1B
Enterprise ValueMkt cap + debt − cash-$2M$56.1B$93.8B$49.1B$11.6B
Trailing P/EPrice ÷ TTM EPS0.00x32.12x29.25x28.72x21.56x
Forward P/EPrice ÷ next-FY EPS est.14.52x19.28x17.94x13.26x
PEG RatioP/E ÷ EPS growth rate0.75x6.84x
EV / EBITDAEnterprise value multiple-0.48x11.92x18.74x16.01x10.87x
Price / SalesMarket cap ÷ Revenue0.00x0.15x0.26x0.20x0.61x
Price / BookPrice ÷ Book value/share0.00x28.57x1.79x
Price / FCFMarket cap ÷ FCF0.00x15.51x17.63x23.56x14.12x
RDGT leads this category, winning 5 of 7 comparable metrics.

Profitability & Efficiency

RDGT leads this category, winning 5 of 9 comparable metrics.

MCK delivers a 3.0% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $8 for HSIC. RDGT carries lower financial leverage with a 0.35x debt-to-equity ratio, signaling a more conservative balance sheet compared to COR's 6.15x. On the Piotroski fundamental quality scale (0–9), RDGT scores 6/9 vs HSIC's 4/9, reflecting solid financial health.

MetricRDGT logoRDGTRidgetech Inc.COR logoCORCencora, Inc.MCK logoMCKMcKesson Corporat…CAH logoCAHCardinal Health, …HSIC logoHSICHenry Schein, Inc.
ROE (TTM)Return on equity+29.1%+105.8%+3.0%+8.2%
ROA (TTM)Return on assets+8.7%+3.3%+5.7%+2.8%+3.6%
ROICReturn on invested capital-2.4%+44.5%+5.4%+33.8%+7.1%
ROCEReturn on capital employed-4.1%+23.1%+30.5%+19.2%+9.8%
Piotroski ScoreFundamental quality 0–966664
Debt / EquityFinancial leverage0.35x6.15x0.77x
Net DebtTotal debt minus cash-$2M$6.4B$1.7B$5.5B$3.5B
Cash & Equiv.Liquid assets$13M$4.4B$5.7B$3.9B$156M
Total DebtShort + long-term debt$10M$10.7B$7.4B$9.3B$3.7B
Interest CoverageEBIT ÷ Interest expense3.73x33.79x6.38x4.59x
RDGT leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CAH leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in MCK five years ago would be worth $38,689 today (with dividends reinvested), compared to $0 for RDGT. Over the past 12 months, CAH leads with a +22.0% total return vs RDGT's -99.1%. The 3-year compound annual growth rate (CAGR) favors CAH at 31.5% vs RDGT's -91.6% — a key indicator of consistent wealth creation.

MetricRDGT logoRDGTRidgetech Inc.COR logoCORCencora, Inc.MCK logoMCKMcKesson Corporat…CAH logoCAHCardinal Health, …HSIC logoHSICHenry Schein, Inc.
YTD ReturnYear-to-date-99.6%-24.4%-8.5%-9.5%-8.2%
1-Year ReturnPast 12 months-99.1%-15.3%+4.6%+22.0%+5.9%
3-Year ReturnCumulative with dividends-99.9%+55.8%+106.4%+127.3%-11.7%
5-Year ReturnCumulative with dividends-100.0%+119.9%+286.9%+235.7%-12.5%
10-Year ReturnCumulative with dividends-100.0%+269.7%+348.1%+160.8%+5.3%
CAGR (3Y)Annualised 3-year return-91.6%+15.9%+27.3%+31.5%-4.0%
CAH leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

CAH leads this category, winning 2 of 2 comparable metrics.

CAH is the less volatile stock with a 0.03 beta — it tends to amplify market swings less than RDGT's 1.10 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CAH currently trades 79.3% from its 52-week high vs RDGT's 0.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricRDGT logoRDGTRidgetech Inc.COR logoCORCencora, Inc.MCK logoMCKMcKesson Corporat…CAH logoCAHCardinal Health, …HSIC logoHSICHenry Schein, Inc.
Beta (5Y)Sensitivity to S&P 5001.10x0.13x0.04x0.03x0.73x
52-Week HighHighest price in past year$760.50$377.54$999.00$233.60$89.29
52-Week LowLowest price in past year$1.23$244.82$637.00$137.75$61.95
% of 52W HighCurrent price vs 52-week peak+0.2%+67.7%+75.3%+79.3%+79.0%
RSI (14)Momentum oscillator 0–10032.816.816.233.239.1
Avg Volume (50D)Average daily shares traded59.4M1.5M757K1.7M1.2M
CAH leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — COR and CAH each lead in 1 of 2 comparable metrics.

Analyst consensus: COR as "Buy", MCK as "Buy", CAH as "Buy", HSIC as "Hold". Consensus price targets imply 60.0% upside for COR (target: $409) vs 22.6% for HSIC (target: $86). For income investors, CAH offers the higher dividend yield at 1.10% vs MCK's 0.36%.

MetricRDGT logoRDGTRidgetech Inc.COR logoCORCencora, Inc.MCK logoMCKMcKesson Corporat…CAH logoCAHCardinal Health, …HSIC logoHSICHenry Schein, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuyBuyHold
Price TargetConsensus 12-month target$409.14$1006.50$249.67$86.43
# AnalystsCovering analysts46313332
Dividend YieldAnnual dividend ÷ price+0.9%+0.4%+1.1%
Dividend StreakConsecutive years of raises2417201
Dividend / ShareAnnual DPS$2.24$2.69$2.04
Buyback YieldShare repurchases ÷ mkt cap0.0%+0.9%+3.4%+1.8%+10.5%
Evenly matched — COR and CAH each lead in 1 of 2 comparable metrics.
Key Takeaway

RDGT leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). CAH leads in 2 (Total Returns, Risk & Volatility). 1 tied.

Best OverallRidgetech Inc. (RDGT)Leads 2 of 6 categories
Loading custom metrics...

RDGT vs COR vs MCK vs CAH vs HSIC: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is RDGT or COR or MCK or CAH or HSIC a better buy right now?

For growth investors, McKesson Corporation (MCK) is the stronger pick with 16.

2% revenue growth year-over-year, versus -22. 4% for Ridgetech Inc. (RDGT). Henry Schein, Inc. (HSIC) offers the better valuation at 21. 6x trailing P/E (13. 3x forward), making it the more compelling value choice. Analysts rate Cencora, Inc. (COR) a "Buy" — based on 46 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — RDGT or COR or MCK or CAH or HSIC?

On trailing P/E, Henry Schein, Inc.

(HSIC) is the cheapest at 21. 6x versus Cencora, Inc. at 32. 1x. On forward P/E, Henry Schein, Inc. is actually cheaper at 13. 3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: McKesson Corporation wins at 0. 49x versus Henry Schein, Inc. 's 4. 21x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — RDGT or COR or MCK or CAH or HSIC?

Over the past 5 years, McKesson Corporation (MCK) delivered a total return of +286.

9%, compared to -100. 0% for Ridgetech Inc. (RDGT). Over 10 years, the gap is even starker: MCK returned +348. 1% versus RDGT's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — RDGT or COR or MCK or CAH or HSIC?

By beta (market sensitivity over 5 years), Cardinal Health, Inc.

(CAH) is the lower-risk stock at 0. 03β versus Ridgetech Inc. 's 1. 10β — meaning RDGT is approximately 3141% more volatile than CAH relative to the S&P 500. On balance sheet safety, Ridgetech Inc. (RDGT) carries a lower debt/equity ratio of 35% versus 6% for Cencora, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — RDGT or COR or MCK or CAH or HSIC?

By revenue growth (latest reported year), McKesson Corporation (MCK) is pulling ahead at 16.

2% versus -22. 4% for Ridgetech Inc. (RDGT). On earnings-per-share growth, the picture is similar: Ridgetech Inc. grew EPS 162. 8% year-over-year, compared to 5. 7% for Cencora, Inc.. Over a 3-year CAGR, MCK leads at 10. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — RDGT or COR or MCK or CAH or HSIC?

Ridgetech Inc.

(RDGT) is the more profitable company, earning 8. 5% net margin versus 0. 5% for Cencora, Inc. — meaning it keeps 8. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HSIC leads at 5. 7% versus -0. 9% for RDGT. At the gross margin level — before operating expenses — HSIC leads at 29. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is RDGT or COR or MCK or CAH or HSIC more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, McKesson Corporation (MCK) is the more undervalued stock at a PEG of 0. 49x versus Henry Schein, Inc. 's 4. 21x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Henry Schein, Inc. (HSIC) trades at 13. 3x forward P/E versus 19. 3x for McKesson Corporation — 6. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for COR: 60. 0% to $409. 14.

08

Which pays a better dividend — RDGT or COR or MCK or CAH or HSIC?

In this comparison, CAH (1.

1% yield), COR (0. 9% yield), MCK (0. 4% yield) pay a dividend. RDGT, HSIC do not pay a meaningful dividend and should not be held primarily for income.

09

Is RDGT or COR or MCK or CAH or HSIC better for a retirement portfolio?

For long-horizon retirement investors, Cardinal Health, Inc.

(CAH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 03), 1. 1% yield, +160. 8% 10Y return). Both have compounded well over 10 years (CAH: +160. 8%, RDGT: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between RDGT and COR and MCK and CAH and HSIC?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: RDGT is a small-cap quality compounder stock; COR is a mid-cap quality compounder stock; MCK is a mid-cap high-growth stock; CAH is a mid-cap quality compounder stock; HSIC is a small-cap quality compounder stock. COR, CAH pay a dividend while RDGT, MCK, HSIC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

RDGT

Quality Business

  • Sector: Healthcare
  • Market Cap > $500M
Run This Screen
Stocks Like

COR

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

MCK

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

CAH

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

HSIC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 17%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform RDGT and COR and MCK and CAH and HSIC on the metrics below

Revenue Growth>
%
(RDGT: -11.7% · COR: 3.8%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.